M. Peter Marinkovich, MD

4.6/5

Biography

Peter Marinkovich, M.D., is an Associate Professor of Dermatology, a faculty member of the Program in Epithelial Biology and the Stanford Cancer Biology Program. He has an interest in inflammatory skin disease and is Director of the Stanford Bullous Disease and Psoriasis Clinics as well as an attending dermatologist at the VA Palo Alto Medical Center. Dr. Marinkovich’s research focuses on pathogenesis and therapy of epidermolysis bullosa, autoimmune blistering diseases, psoriasis and skin cancer.

View Full Biography

Professional Summary

Education & Certifications

Board Certified, American Board of Dermatology (ABD), Dermatology (1995)
Dermatology Resident Physician, Oregon Health & Science University (OHSU), Dermatology (1994)
Postdoctoral Research Fellowship, Shriners Hospital for Crippled Children, Portland, Oregon, Dermatology (1991)
- Medical Internship, University of California San Francisco, San Joaquin Valley PRIME+ Program, Clinical Residency (Internal Medicine) (1989)
- Medical Director, Saint Louis University School of Medicine, Medical Education (1988)
- BA with Honors, University of California Santa Cruz, Biology (1984)

View More Education & Certifications

Honors & Awards

1st Annual Jouni Uitto Impact Award, debra of America Annual Benefit (2023)
First Place Award, Oregon Health & Science University (OHSU) Alumni Assocation (1992)
Gold Award, American Academy of Dermatology (AAD) Association (1990)
- Harrington Scholar-Innovator Award, Harrington Discovery Institute (2016)
- Nelson Paul Anderson Essay Award, Pacific Dermatologic Association (1992)
- Setekwagon Award, American Academy of Dermatology (AAD) Association (1993)

View More Honors & Awards

Memberships

Program Committee, EB Clinet (2025 - Present)
Committee Member, Dermatology Diversity and Inclusion Committee, Stanford University School of Medicine (2022 - Present)
Member, Society for Investigative Dermatology (SID) (2021 - Present)
- Senior Member, American Dermatological Association (ADA) (2015 - 2016)
- Member, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine (2011 - Present)
- Member, Medical Institutional Board Review 4, Stanford University School of Medicine (2005 - Present)
- Member, Cancer Center, Stanford University School of Medicine (2004 - Present)
- AAD Fellow, American Academy of Dermatology (AAD) Association (1997 - Present)

View More Memberships

Administrative Appointments

Attending Physician, Palo Alto VA Medical Center, Dermatology (1995 - Present)
Director, Blistering Disease Clinic, Department of Dermatology, Stanford University School of Medicine (1995 - Present)
Site Investigator, National Epidermolysis Bullosa Registry, Stanford University School of Medicine (1995 - Present)

Publications

Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen
Chan, L. S., Lapiere, J. C., Chen, M., Traczyk, T., Mancini, A. J., Paller, A. S., … Marinkovich, M. P. (1999). Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. ARCHIVES OF DERMATOLOGY, 135(5), 569–73.
BP180 gene delivery in junctional epidermolysis bullosa
Seitz, C. S., Giudice, G. J., Balding, S. D., Marinkovich, M. P., & Khavari, P. A. (1999). BP180 gene delivery in junctional epidermolysis bullosa. GENE THERAPY, 6(1), 42–47.
Gene therapy for a lethal genetic blistering disease: a status report.
BAUER, E. A., Herron, G. S., Marinkovich, M. P., Khavari, P. A., & Lane, A. T. (1999). Gene therapy for a lethal genetic blistering disease: a status report. Transactions of the American Clinical and Climatological Association, 110, 86–92.
- Melanocytes adhere to and synthesize laminin-5 in vitro
  Scott, G. A., Cassidy, L., Tran, H., Rao, S. K., & Marinkovich, M. P. (1999). Melanocytes adhere to and synthesize laminin-5 in vitro. EXPERIMENTAL DERMATOLOGY, 8(3), 212–21.
- Update on inherited bullous dermatoses
  Marinkovich, M. P. (1999). Update on inherited bullous dermatoses. DERMATOLOGIC CLINICS, 17(3), 473-?
- Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2)
  Olivry, T., Chan, L. S., Xu, L., Chace, P., Dunston, S. M., Fahey, M., & Marinkovich, M. P. (1999). Novel feline autoimmune blistering disease resembling bullous pemphigoid in humans: IgG autoantibodies target the NC16A ectodomain of type XVII collagen (BP180/BPAG2). VETERINARY PATHOLOGY, 36(4), 328–35.
- Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa
  Olivry, T., Dunston, S. M., & Marinkovich, M. P. (1999). Reduced anchoring fibril formation and collagen VII immunoreactivity in feline dystrophic epidermolysis bullosa. VETERINARY PATHOLOGY, 36(6), 616–618.
- Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa
  Pulkkinen, L., Marinkovich, M. P., Tran, H. T., Lin, L., Herron, G. S., & Uitto, J. (1999). Compound heterozygosity for novel splice site mutations in the BPAG2/COL17A1 gene underlies generalized atrophic benign epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 113(6), 1114–18.
- Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen
  Kawahara, Y., Zillikens, D., Yancey, K. B., Marinkovich, M. P., Nie, Z., Hashimoto, T., & Nishikawa, T. (2000). Subepidermal blistering disease with autoantibodies against a novel dermal 200-kDa antigen. JOURNAL OF DERMATOLOGICAL SCIENCE, 23(2), 93–102.
- Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans
  Olivry, T., Dunston, S. M., Fahey, M., Nguyen, N., & Marinkovich, M. P. (2000). Autoantibodies against the processed ectodomain of collagen XVII (BPAG2, BP180) define a canine homologue of linear IgA disease of humans. VETERINARY PATHOLOGY, 37(4), 302–9.
- Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding
  Areida, S. K., Reinhardt, D. P., Muller, P. K., FIETZEK, P. P., Kowitz, J., Marinkovich, M. P., & Notbohm, H. (2001). Properties of the collagen type XVII ectodomain - Evidence for N- to C-terminal triple helix folding. JOURNAL OF BIOLOGICAL CHEMISTRY, 276(2), 1594–1601.
- Laminins and human disease
  McGowan, K. A., & Marinkovich, M. P. (2000). Laminins and human disease. MICROSCOPY RESEARCH AND TECHNIQUE, 51(3), 262–79.
- Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes
  Schmidt, E., Reimer, S., Kruse, N., Jainta, S., Brocker, E. B., Marinkovich, M. P., … Zillikens, D. (2000). Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 115(5), 842–48.
- IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain
  Egan, C. A., Reddy, E. D., Nie, Z. X., Taylor, T. B., Schmidt, L. A., Meyer, L. J., … Zone, J. J. (2001). IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 116(2), 348–50.
- A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions
  Olivry, T., Dunston, S. M., Schachter, M., Xu, L. T., Nguyen, N., Marinkovich, M. P., & Chan, L. S. (2001). A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions. JOURNAL OF AUTOIMMUNITY, 16(4), 411–21.
- Linear IgA bullous dermatosis
  Guide, S. V., & Marinkovich, M. P. (2001). Linear IgA bullous dermatosis. CLINICS IN DERMATOLOGY, 19(6), 719–27.
- The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators
  Chan, L. S., Ahmed, A. R., ANHALT, G. J., Bernauer, W., Cooper, K. D., Elder, M. J., … Zone, J. J. (2002). The first international consensus on mucous membrane pemphigoid - Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. ARCHIVES OF DERMATOLOGY, 138(3), 370–79.
- Epidermolysis bullosa: new and emerging trends.
  Pai, S., & Marinkovich, M. P. (2002). Epidermolysis bullosa: new and emerging trends. American Journal of Clinical Dermatology, 3(6), 371–80.
- Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin
  Veitch, D. P., Nokelainen, P., McGowan, K. A., Nguyen, T. T., Nguyen, N. E., Stephenson, R., … Marinkovich, P. M. (2003). Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 278(18), 15661–68.
- Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue
  Ortiz-Urda, S., Lin, Q., Green, C. L., Keene, D. R., Marinkovich, M. P., & Khavari, P. A. (2003). Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. JOURNAL OF CLINICAL INVESTIGATION, 111(2), 251–55.
- NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia
  Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., … Khavari, P. A. (2003). NF-kappa B blockade and oncogenic Ras trigger invasive human epidermal neoplasia. NATURE, 421(6923), 639–43.
- Laminin-10 is crucial for hair morphogenesis
  Li, J., Tzu, J., Chen, Y., Zhang, Y. P., Nguyen, N. T., Gao, J., … Marinkovich, M. P. (2003). Laminin-10 is crucial for hair morphogenesis. EMBO JOURNAL, 22(10), 2400–2410.
- Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid
  Chu, J., Bradley, M., & Marinkovich, M. P. (2003). Topical tacrolimus is a useful adjunctive therapy for bullous pemphigoid. ARCHIVES OF DERMATOLOGY, 139(6), 813–15.
- alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin
  Russell, A. J., Fincher, E. F., Millman, L., Smith, R., Vela, V., Waterman, E. A., … Marinkovich, M. P. (2003). alpha 6 beta 4 integrin regulates keratinocyte chemotaxis through differential GTPase activation and antagonism of alpha 3 beta 1 integrin. JOURNAL OF CELL SCIENCE, 116(17), 3543–56.
- Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients.
  Meneguzzi, G., Marinkovich, M. P., Aberdam, D., Pisani, A., Burgeson, R., & Ortonne, J. P. (1992). Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients. Experimental Dermatology, 1(5), 221–229.
- THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT
  Marinkovich, M. P., Lunstrum, G. P., Keene, D. R., & Burgeson, R. E. (1992). THE DERMAL EPIDERMAL JUNCTION OF HUMAN SKIN CONTAINS A NOVEL LAMININ VARIANT. JOURNAL OF CELL BIOLOGY, 119(3), 695–703.
- IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN
  Lunstrum, G. P., McDonough, A. M., Marinkovich, M. P., Keene, D. R., Morris, N. P., & Burgeson, R. E. (1992). IDENTIFICATION AND PARTIAL-PURIFICATION OF A LARGE, VARIANT FORM OF TYPE-XII COLLAGEN. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(28), 20087–20092.
- Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors
  Zahir, N., Lakins, J. N., Russell, A., Ming, W. Y., Chatterjee, C., Rozenberg, G. I., … Weaver, V. M. (2003). Autocrine laminin-5 ligates alpha 6 beta 4 integrin and activates RAC and NF kappa B to mediate anchorage-independent survival of mammary tumors. JOURNAL OF CELL BIOLOGY, 163(6), 1397–1407.
- Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44
  Vivinus-Nebot, M., Rousselle, P., Breittmayer, J. P., Cenciarini, C., Berrih-Aknin, S., Spong, S., … Bernard, A. (2004). Mature human thymocytes migrate on laminin-5 with activation of metalloproteinase-14 and cleavage of CD44. JOURNAL OF IMMUNOLOGY, 172(3), 1397–1406.
- Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis
  Chang, H. Y., Cooper, Z. A., Swetter, S. A., & Marinkovich, M. P. (2004). Kinetics and specificity of Fas ligand induction in toxic epidermal necrolysis. ARCHIVES OF DERMATOLOGY, 140(2), 242–44.
- THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR
  Marinkovich, M. P., Lunstrum, G. P., & Burgeson, R. E. (1992). THE ANCHORING FILAMENT PROTEIN KALININ IS SYNTHESIZED AND SECRETED AS A HIGH-MOLECULAR-WEIGHT PRECURSOR. JOURNAL OF BIOLOGICAL CHEMISTRY, 267(25), 17900–17906.
- Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma
  Arbiser, J. L., Fan, C. Y., Su, X. B., van Emburgh, B. O., Cerimele, F., Miller, M. S., … Marinkovich, M. P. (2004). Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 123(4), 788–90.
- Type VII collagen is required for Ras-driven human epidermal tumorigenesis
  Ortiz-Urda, S., Garcia, J., Green, C. L., Chen, L., Lin, Q., Veitch, D. P., … Khavari, P. A. (2005). Type VII collagen is required for Ras-driven human epidermal tumorigenesis. SCIENCE, 307(5716), 1773–76.
- A simplified laminin nomenclature
  Aumailley, M., Bruckner-Tuderman, L., Carter, W. G., Deutzmann, R., Edgar, D., Ekblom, P., … Yurchenco, P. D. (2005). A simplified laminin nomenclature. MATRIX BIOLOGY, 24(5), 326–32.
- Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions
  Li, J., Zhou, L., Tran, H. T., Chen, Y., Nguyen, N. E., Karasek, M. A., & Marinkovich, M. P. (2006). Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126(2), 432–40.
- beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1
  Pullar, C. E., Baier, B. S., Kariya, Y., Russell, A. J., Horst, B. A. J., Marinkovich, M. P., & Isseroff, R. R. (2006). beta 4 integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. MOLECULAR BIOLOGY OF THE CELL, 17(11), 4925–35.
- Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells
  Culp, T. D., Budgeon, L. R., Marinkovich, M. P., Meneguzzi, G., & Christensen, N. D. (2006). Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. JOURNAL OF VIROLOGY, 80(18), 8940–50.
- Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization
  Sehgal, B. U., DeBiase, P. J., Matzno, S., Chew, T.-L., Claiborne, J. N., Hopkinson, S. B., … Jones, J. C. R. (2006). Integrin beta 4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. JOURNAL OF BIOLOGICAL CHEMISTRY, 281(46), 35487–98.
- Tumour microenvironment: laminin 332 in squamous-cell carcinoma.
  Marinkovich, M. P. (2007). Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nature Reviews. Cancer, 7(5), 370–80.
- A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation
  Waterman, E. A., Sakai, N., Nguyen, N. T., Horst, B. A. J., Veitch, D. P., Dey, C. N., … Marinkovich, M. P. (2007). A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. CANCER RESEARCH, 67(9), 4264–70.
- What's new in blistering disorders?
  Chaudbari, P., & Marinkovich, M. P. (2007). What's new in blistering disorders? CURRENT ALLERGY AND ASTHMA REPORTS, 7(4), 255–63.
- Bridging structure with function: Structural, regulatory, and developmental role of laminins
  Tzu, J., & Marinkovich, M. P. (2008). Bridging structure with function: Structural, regulatory, and developmental role of laminins. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 40(2), 199–214.
- Targeting a tumor-specific laminin domain critical for human carcinogenesis
  Tran, M., Rousselle, P., Nokelainen, P., Tallapragada, S., Nguyen, N. T., Fincher, E. F., & Marinkovich, M. P. (2008). Targeting a tumor-specific laminin domain critical for human carcinogenesis. CANCER RESEARCH, 68(8), 2885–94.
- Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis
  Gao, J., DeRouen, M. C., Chen, C.-H., Nguyen, M., Nguyen, N. T., Ido, H., … Marinkovich, M. P. (2008). Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis. GENES & DEVELOPMENT, 22(15), 2111–24.
- Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies
  Nguyen, B., Dusek, R. L., Beaudry, V. G., Marinkovich, M. P., & Attardi, L. D. (2009). Loss of the Desmosomal Protein Perp Enhances the Phenotypic Effects of Pemphigus Vulgaris Autoantibodies. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 129(7), 1710–18.
- Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders
  Ko, M. S., & Marinkovich, M. P. (2010). Role of Dermal-Epidermal Basement Membrane Zone in Skin, Cancer, and Developmental Disorders. DERMATOLOGIC CLINICS, 28(1), 1-?
- Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules
  Sakai, N., Waterman, E. A., Nguyen, N. T., Keene, D. R., & Marinkovich, M. P. (2010). Observations of Skin Grafts Derived from Keratinocytes Expressing Selectively Engineered Mutant Laminin-332 Molecules. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130(8), 2147–50.
- Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue
  Siprashvili, Z., Nguyen, N. T., Bezchinsky, M. Y., Marinkovich, M. P., Lane, A. T., & Khavari, P. A. (2010). Long-Term Type VII Collagen Restoration to Human Epidermolysis Bullosa Skin Tissue. HUMAN GENE THERAPY, 21(10), 1299–1310.
- Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation
  DeRouen, M. C., Zhen, H., Tan, S. H., Williams, S., Marinkovich, M. P., & Oro, A. E. (2010). Laminin-511 and integrin beta-1 in hair follicle development and basal cell carcinoma formation. BMC DEVELOPMENTAL BIOLOGY, 10.
- Discovery of basement membrane components.
  Marinkovich, M. P. (2008). Discovery of basement membrane components. Journal of Investigative Dermatology, 128(E2), E3–4.
- Molecular organization of the basement membrane zone
  Hashmi, S., & Marinkovich, M. P. (2011). Molecular organization of the basement membrane zone. CLINICS IN DERMATOLOGY, 29(4), 398–411.
- Linear immunoglobulin A bullous dermatosis
  Fortuna, G., & Marinkovich, M. P. (2012). Linear immunoglobulin A bullous dermatosis. CLINICS IN DERMATOLOGY, 30(1), 38–50.
- A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity?
  Fortuna, G., Cesar Salas-Alanis, J., Guidetti, E., & Marinkovich, M. P. (2012). A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: A real and separate nosological entity? JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 66(6), 988–94.
- Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment.
  Fortuna, G., Chainani-Wu, N., Lozada-Nur, F., Aria, M., Cepeda-Valdes, R., Pollio, A., … Salas-Alanís, J. C. (2013). Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment. Journal of the American Academy of Dermatology, 68(1), 83–92.
- Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications
  Sun, W., Araci, Z., Inayathullah, M., Manickam, S., Zhang, X., Bruce, M. A., … Butte, M. J. (2013). Polyvinylpyrrolidone microneedles enable delivery of intact proteins for diagnostic and therapeutic applications. ACTA BIOMATERIALIA, 9(8), 7767–74.
- SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION
  Hom, Y. K., Marinkovich, M. P., Lozano, J. J., & Rocha, V. (1989). SYNTHESIS OF CALELECTRINS AND CALPACTIN-I DURING CYTOCHALASIN MEDIATED CELL SPREADING INHIBITION. CELL CALCIUM, 10(3), 135–144.
- BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING
  Rocha, V., Hom, Y. K., & Marinkovich, M. P. (1986). BASAL LAMINA INHIBITION SUPPRESSES SYNTHESIS OF CALCIUM-DEPENDENT PROTEINS ASSOCIATED WITH MAMMARY EPITHELIAL-CELL SPREADING. EXPERIMENTAL CELL RESEARCH, 165(2), 450–460.
- COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS
  Marinkovich, M. P., & Rocha, V. (1986). COLLAGEN-SYNTHESIS AND DEPOSITION DURING MAMMARY EPITHELIAL-CELL SPREADING ON COLLAGEN GELS. JOURNAL OF CELLULAR PHYSIOLOGY, 128(1), 61–70.
- ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5
  Kirtschig, G., Marinkovich, M. P., Burgeson, R. E., & Yancey, K. B. (1995). ANTIBASEMENT MEMBRANE AUTOANTIBODIES IN PATIENTS WITH ANTI-EPILIGRIN CICATRICIAL PEMPHIGOID BIND THE ALPHA-SUBUNIT OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(4), 543–548.
- A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5
  Chan, L. S., Wang, X. S., Lapiere, J. C., Marinkovich, M. P., Jones, J. C. R., & Woodley, D. T. (1995). A NEWLY IDENTIFIED 105-KD LOWER LAMINA-LUCIDA AUTOANTIGEN IS AN ACIDIC PROTEIN DISTINCT FROM THE 105-KD GAMMA-2 CHAIN OF LAMININ-5. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(1), 75–79.
- NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE
  Marinkovich, M. P., Botella, R., DATLOFF, J., & Sangueza, O. P. (1995). NECROLYTIC MIGRATORY ERYTHEMA WITHOUT GLUCAGONOMA IN PATIENTS WITH LIVER-DISEASE. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 32(4), 604–9.
- THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES
  Marinkovich, M. P. (1993). THE MOLECULAR-GENETICS OF BASEMENT-MEMBRANE DISEASES. ARCHIVES OF DERMATOLOGY, 129(12), 1557–65.
- CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE
  Marinkovich, M. P., Keene, D. R., RIMBERG, C. S., & Burgeson, R. E. (1993). CELLULAR-ORIGIN OF THE DERMAL-EPIDERMAL BASEMENT-MEMBRANE. DEVELOPMENTAL DYNAMICS, 197(4), 255–67.
- BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL
  Marinkovich, M. P., Verrando, P., Keene, D. R., Meneguzzi, G., Lunstrum, G. P., Ortonne, J. P., & Burgeson, R. E. (1993). BASEMENT-MEMBRANE PROTEINS KALININ AND NICEIN ARE STRUCTURALLY AND IMMUNOLOGICALLY IDENTICAL. LABORATORY INVESTIGATION, 69(3), 295–99.
- PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS
  Marinkovich, M. P., Meneguzzi, G., Burgeson, R. E., BLANCHETBARDON, C., Holbrook, K. A., Smith, L. T., … Ortonne, J. P. (1995). PRENATAL-DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS-BULLOSA BY AMNIOCENTESIS. PRENATAL DIAGNOSIS, 15(11), 1027–34.
- LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells
  Marinkovich, M. P., Taylor, T. B., Keene, D. R., Burgeson, R. E., & Zone, J. J. (1996). LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 734–38.
- A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone
  Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(3), 465–70.
- A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone.
  Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. Journal of Investigative Dermatology, 106(6), 1333–1338.
- Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin
  Chen, M., Marinkovich, M. P., Veis, A., Cai, X. Y., Rao, C. N., OToole, E. A., & Woodley, D. T. (1997). Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components - A potential role in epidermal-dermal adherence in human skin. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(23), 14516–22.
- Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid
  Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., Chen, M., … Marinkovich, M. P. (1997). Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(6), 848–53.
- Laminin-5 inhibits human keratinocyte migration
  OToole, E. A., Marinkovich, M. P., Hoeffler, W. K., FURTHMAYR, H., & Woodley, D. T. (1997). Laminin-5 inhibits human keratinocyte migration. EXPERIMENTAL CELL RESEARCH, 233(2), 330–39.
- LAD-1 is absent in a subset of junctional epidermolysis bullosa patients
  Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., Jonkman, M. F., … BRUCKNERTUDERMAN, L. (1997). LAD-1 is absent in a subset of junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 109(3), 356–59.
- Immunodissection of the connective tissue matrix in human skin
  Keene, D. R., Marinkovich, M. P., & Sakai, L. Y. (1997). Immunodissection of the connective tissue matrix in human skin. MICROSCOPY RESEARCH AND TECHNIQUE, 38(4), 394–406.
- Hypoxia increases human keratinocyte motility on connective tissue
  O'Toole, E. A., Marinkovich, M. P., Peavey, C. L., Amieva, M. R., FURTHMAYR, H., Mustoe, T. A., & Woodley, D. T. (1997). Hypoxia increases human keratinocyte motility on connective tissue. JOURNAL OF CLINICAL INVESTIGATION, 100(11), 2881–91.
- Self-assembly of laminin isoforms
  Cheng, Y. S., Champliaud, M. F., Burgeson, R. E., Marinkovich, M. P., & Yurchenco, P. D. (1997). Self-assembly of laminin isoforms. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(50), 31525–32.
- NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats
  Chen, M., Marinkovich, M. P., Jones, J. C. R., O'Toole, E. A., Li, Y. Y., & Woodley, D. T. (1999). NC1 domain of type VII collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(2), 177–83.
- Activation of the small GTPase Rac1 alters localization of integrin alpha 3 beta 1 leading to disruption of Hemidesmosome formation
  Chu, J., Russell, A. J., & Marinkovich, M. P. (2002). Activation of the small GTPase Rac1 alters localization of integrin alpha 3 beta 1 leading to disruption of Hemidesmosome formation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 229–29.
- Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice
  Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., Keene, D. R., … Senior, R. M. (2012). Keratinocyte-Targeted Expression of Human Laminin gamma 2 Rescues Skin Blistering and Early Lethality of Laminin gamma 2 Deficient Mice. PLOS ONE, 7(9).
- Human microvascular endothelial cells produce a novel laminin variant.
  Tran, H. H., Rao, S. K., Zhang, D. N., Romero, L., Khush, K., Herron, G. S., & Marinkovich, M. P. (1996). Human microvascular endothelial cells produce a novel laminin variant. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 143–43.
- Laminins 8 and 10 in skin basement membrane reconstitution and wound healing
  Li, J., Zhu, L., Kirsner, R. S., Davis, S. C., Mertz, P. M., Eaglstein, W. H., … Zhang, Y. (2004). Laminins 8 and 10 in skin basement membrane reconstitution and wound healing. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A31–A31.
- Processing of laminin-5 in keratinocyte migration
  Veitch, D. P., McGowan, K., Findell, P., Sharma, P., & Marinkovich, M. P. (2000). Processing of laminin-5 in keratinocyte migration. AMER SOC CELL BIOLOGY.
- Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice.
  Adair-Kirk, T. L., Griffin, G. L., Meyer, M. J., Kelley, D. G., Miner, J. H., Keene, D. R., … Senior, R. M. (2012). Keratinocyte-targeted expression of human laminin ?2 rescues skin blistering and early lethality of laminin ?2 deficient mice. PloS One, 7(9).
- Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
  Liu, Z., Sui, W., Zhao, M., Li, Z., Li, N., Thresher, R., … Diaz, L. A. (2008). Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. JOURNAL OF AUTOIMMUNITY, 31(4), 331–38.
- Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies
  Olivry, T., Bizikova, P., Dunston, S. M., Bond, R., Halliwell, R., Loeffler, A., … Marinkovich, M. P. (2010). Clinical and immunological heterogeneity of canine subepidermal blistering dermatoses with anti-laminin-332 (laminin-5) auto-antibodies. VETERINARY DERMATOLOGY, 21(4), 345–57.
- Multiple functions for beta 4 integrin in human microvascular endothelial cells
  Marinkovich, M., Zhou, L., Russell, A., Li, J., & Karasek, M. (2001). Multiple functions for beta 4 integrin in human microvascular endothelial cells. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 391–91.
- A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone (vol 106, pg 465, 1996)
  Zillikens, D., Kawahara, Y., Ishiko, A., Shimizu, H., Mayer, J., Rank, C. V., … Hashimoto, T. (1996). A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone (vol 106, pg 465, 1996). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(6), 1332–38.
- BP180 gene transfer and expression in benign junctional epidermolysis bullosa.
  Seitz, C. S., Marinkovich, M. P., Tran, H., Janoff, M., Diaz, L. A., OToole, E. A., … Khavari, P. A. (1997). BP180 gene transfer and expression in benign junctional epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 305–.
- LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients
  Marinkovich, M. P., Tran, H. H., Rao, S. K., Giudice, G. J., Balding, S., Jonkman, M. F., … BRUCKNERTUDERMAN, L. (1996). LAD-1 is absent in a subset of generalized atrophic benign junctional epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 281–81.
- Laminin-5 is synthesized by normal human melanocytes, but not melanoma cells, and is a ligand for melanocytes in vivo.
  Scott, G. A., Cassidy, L., Tran, H. H., Rao, S. K., & Marinkovich, M. P. (1996). Laminin-5 is synthesized by normal human melanocytes, but not melanoma cells, and is a ligand for melanocytes in vivo. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 130–30.
- Laminin-B is a lamina, densa autoantigen ih oral pemphigoid.
  Chan, L. S., MAJMUDAR, A. A., Tran, H. H., Meier, F., SCHAUMBURGLEVER, G., Chen, M., … Marinkovich, M. P. (1996). Laminin-B is a lamina, densa autoantigen ih oral pemphigoid. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 41–41.
- Identification of multiple, distinct cicatritial pemphigoid autoantigens.
  Rao, S. K., Tran, H. H., Allen, J., Wojnarowska, F., & Marinkovich, M. P. (1996). Identification of multiple, distinct cicatritial pemphigoid autoantigens. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 39–39.
- LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180.
  Tran, H. H., Schumann, H., Balding, S., Giudice, G. J., BRUCKNERTUDERMAN, L., & Marinkovich, M. P. (1997). LAD-1 is a collagenous component of keratinocyte adhesion complexes which assembles into a high molecular weight complex and which has homology to BP180. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 289–89.
- Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion
  Tran, M. M., Rousselle, P., Nokelainen, P., Nguyen, N., Keene, D. R., Fincher, E. F., & Marinkovich, M. P. (2006). Laminin-5 alpha 3 G4-5 inhibition ablates epidermal tumorigenesis through PI3K-Akt pathway inactivation but does not disrupt normal epithelial cohesion. Presented at the 67th Annual Meeting of the Society-for-Investigative-Dermatology, PHILADELPHIA,PA,PA,PA,PA,PA,PA: NATURE PUBLISHING GROUP.
- Observations of epidermal grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules
  Sakai, N., Waterman, E., Nguyen, N., Keene, D., Kawana, S., & Marinkovich, M. P. (2008). Observations of epidermal grafts derived from keratinocytes expressing selectively engineered mutant laminin-332 molecules. Presented at the International Investigative Dermatology Meeting, KYOTO,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN: NATURE PUBLISHING GROUP.
- Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis
  Ortiz-Urda, S., Garcia, J., Marinkovich, M., & Khavari, P. (2005). Type VII collagen is required for cellular invasiveness in epidermal carcinogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A25–A25.
- Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression
  Horst, B. A., Russell, A., Nguyen, N., & Marinkovich, M. P. (2007). Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression. Presented at the 96th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, SAN DIEGO,CA,CA,CA,CA,CA,CA: NATURE PUBLISHING GROUP.
- Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development
  Horst, B. A., Nokelainen, P., Fincher, E. F., Nguyen, N. T., Russell, A. J., & Marinkovich, M. P. (2004). Identification of critical domains of beta 4 integrin and laminin-5 required for human SCC development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 122(3), A19–A19.
- A processed laminin-332 domain selectively localizes to and potentiates carcinoma development
  Tran, M. M., Rousselle, P., Nokelainen, N. P., Talapragada, S., Nguyen, N., & Marinkovich, M. P. (2007). A processed laminin-332 domain selectively localizes to and potentiates carcinoma development. Presented at the 37th Annual Meeting of the European-Society-for-Dermatological-Research, ZURICH,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND,SWITZERLAND: NATURE PUBLISHING GROUP.
- Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion
  Waterman, E. A., Ortiz-Urda, S., Nguyen, N. T., Veitch, D. P., Horst, B. A., Dey, C. N., … Marinkovich, M. P. (2005). Two distinct roles for the laminin-5 beta 3 chain in epidermal carcinogenesis and adhesion. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A22–A22.
- Laminin 10 is essential for hair development
  Tzu, J. E., Li, J., Lehman, D., Chen, Y., Nguyen, N. T., Keene, D. R., … Marinkovich, M. (2002). Laminin 10 is essential for hair development. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 291–91.
- Targeting a tumor specific laminin domain critical for human carcinogenesis
  Tran, M. M., Rousselle, P., Tallapragracku, S., Nguyen, N., & Marinkovich, M. P. (2008). Targeting a tumor specific laminin domain critical for human carcinogenesis. Presented at the International Investigative Dermatology Meeting, KYOTO,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN,JAPAN: NATURE PUBLISHING GROUP.
- Identification of binding sites of noncollagenous (NCl) domain of type VII collagen with laminin 5/6 and other extracellular matrix components.
  Chen, M., Marinkovich, M. P., Cai, X. Y., & Woodley, D. T. (1997). Identification of binding sites of noncollagenous (NCl) domain of type VII collagen with laminin 5/6 and other extracellular matrix components. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 108(4), 461–61.
- Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa
  Tolar, J., Xia, L., Lees, C. J., Riddle, M., McElroy, A., Keene, D. R., … Wagner, J. E. (2013). Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133(2), 562–65.
- Diagnosing Epidermolysis Bullosa Type and Subtype in Infancy Using Immunofluorescence Microscopy: The Stanford Experience
  Berk, D. R., Jazayeri, L., Marinkovich, M. P., Sundram, U. N., & Bruckner, A. L. (2013). Diagnosing Epidermolysis Bullosa Type and Subtype in Infancy Using Immunofluorescence Microscopy: The Stanford Experience. PEDIATRIC DERMATOLOGY, 30(2), 226–33.
- Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology
  Fortuna, G., Lozada-Nur, F., Pollio, A., Aria, M., Cepeda-Valdes, R., Marinkovich, M. P., … Cesar Salas-Alanis, J. (2013). Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 42(10), 733–40.
- A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa
  Venugopal, S. S., Yan, W., Frew, J. W., Cohn, H. I., Rhodes, L. M., Kim Tran, K., … Murrell, D. F. (2013). A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 69(6), 898–915.
- Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant.
  Melo, S. P., Lisowski, L., Bashkirova, E., Zhen, H. H., Chu, K., Keene, D. R., … Oro, A. E. (2014). Somatic Correction of Junctional Epidermolysis Bullosa by a Highly Recombinogenic AAV Variant. Molecular Therapy : the Journal of the American Society of Gene Therapy, 22(4), 725–33.
- Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification
  Fine, J.-D., Bruckner-Tuderman, L., Eady, R. A. J., Bauer, E. A., Bauer, J. W., Has, C., … Zambruno, G. (2014). Inherited epidermolysis bullosa: Updated recommendations on diagnosis and classification. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 70(6), 1103–26.
- Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals
  Olivry, T., & Marinkovich, M. P. (2002). Collagen XVII (BP180, BPAG2) is the most common epidermal basement membrane autoantigen in humans and other animals. Presented at the 4th World Conference of Veterinary Dermatology, SAN FRANCISCO,CA: BLACKWELL SCIENCE PUBL.
- Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification.
  Fine, J.-D., Bruckner-Tuderman, L., Eady, R. A. J., Bauer, E. A., Bauer, J. W., Has, C., … Zambruno, G. (2014). Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. Journal of the American Academy of Dermatology, 70(6), 1103–26.
- Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology.
  Fortuna, G., Lozada-Nur, F., Pollio, A., Aria, M., Cepeda-Valdes, R., Marinkovich, M. P., … Salas-Alanís, J. C. (2013). Patterns of oral mucosa lesions in patients with epidermolysis bullosa: comparison and agreement between oral medicine and dermatology. Journal of Oral Pathology & Medicine , 42(10), 733–40.
- Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts
  Murrell, D. F., Marinovic, B., Caux, F., Prost, C., Ahmed, R., Wozniak, K., … Werth, V. P. (2015). Definitions and outcome measures for mucous membrane pemphigoid: Recommendations of an international panel of experts. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 72(1), 168–74.
- Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles
  Sun, W., Inayathullah, M., Manoukian, M. A. C., Malkovskiy, A. V., Manickam, S., Marinkovich, M. P., … Rajadas, J. (2015). Transdermal Delivery of Functional Collagen Via Polyvinylpyrrolidone Microneedles. ANNALS OF BIOMEDICAL ENGINEERING, 43(12), 2978–90.
- RAC1 activation drives pathologic interactions between the epidermis and immune cells
  Winge, M. C. C., Ohyama, B., Dey, C. N., Boxer, L. M., Li, W., Ehsani-Chimeh, N., … Marinkovich, M. P. (2016). RAC1 activation drives pathologic interactions between the epidermis and immune cells. JOURNAL OF CLINICAL INVESTIGATION, 126(7), 2661–77.
- Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
  Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Khuu, P., Furukawa, L. K., … Marinkovich, M. P. (2016). Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA, 316(17), 1808–17.
- Practice and Educational Gaps in Blistering Disease
  Ehsani-Chimeh, N., & Marinkovich, M. P. (2016). Practice and Educational Gaps in Blistering Disease. DERMATOLOGIC CLINICS, 34(3), 251-?
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata.
  Kennedy Crispin, M., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI Insight, 1(15).
- Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment
  Fortuna, G., Chainani-Wu, N., Lozada-Nur, F., Aria, M., Cepeda-Valdes, R., Pollio, A., … Cesar Salas-Alanis, J. (2013). Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: A multicenter development and reliability assessment. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 68(1), 83–92.
- Microtubules acquire resistance from mechanical breakage through intralumenal acetylation
  Xu, Z., Schaedel, L., Portran, D., Aguilar, A., Gaillard, J., Marinkovich, M. P., … Nachury, M. V. (2017). Microtubules acquire resistance from mechanical breakage through intralumenal acetylation. SCIENCE, 356(6335), 328–32.
- BMP1-like proteinases are essential to the structure and wound healing of skin
  Muir, A. M., Massoudi, D., Ngon Nguyen, N., Keene, D. R., Lee, S.-J., Birk, D. E., … Greenspan, D. S. (2016). BMP1-like proteinases are essential to the structure and wound healing of skin. MATRIX BIOLOGY, 56, 114–31.
- Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen.
  Hayakawa, T., Hirako, Y., Teye, K., Tsuchisaka, A., Koga, H., Ishii, N., … Hashimoto, T. (2017). Unique mouse monoclonal antibodies reactive with maturation-related epitopes on type VII collagen. Experimental Dermatology.
- Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn.
  Heinecke, G., Marinkovich, M. P., & Rieger, K. E. (2017). Intraepidermal Type VII Collagen by Immunofluorescence Mapping: A Specific Finding for Bullous Dermolysis of the Newborn. Pediatric Dermatology, 34(3), 308–14.
- Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.
  Woodley, D. T., Cogan, J., Hou, Y., Lyu, C., Marinkovich, M. P., Keene, D., & Chen, M. (2017). Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients. The Journal of Clinical Investigation, 127(8), 3028–38.
- Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis.
  Winge, M. C. G., & Marinkovich, M. P. (2017). Epidermal activation of the small GTPase Rac1 in psoriasis pathogenesis. Small GTPases, 1–6.
- High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization.
  Alcántara-Hernández, M., Leylek, R., Wagar, L. E., Engleman, E. G., Keler, T., Marinkovich, M. P., … Idoyaga, J. (2017). High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization. Immunity.
- Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis
  Marinkovich, M. P. (2018). Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. Chronic Skin Inflammation Accelerates Macrophage Cholesterol Crystal Formation and Atherosclerosis.
- Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD
  Vijayakumar, S., Dang, S., Marinkovich, M. P., Lazarova, Z., Yoder, B., Torres, V. E., & Wallace, D. P. (2014). Aberrant expression of laminin-332 promotes cell proliferation and cyst growth in ARPKD. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 306(6), F640–F654.
- Advances in inherited epidermolysis bullosa.
  McAllister, J. C., & Peter Marinkovich, M. (2005). Advances in inherited epidermolysis bullosa. Advances in Dermatology, 21, 303–34.
- Discovery of Basement Membrane Components.
  Peter Marinkovich, M. (2008). Discovery of Basement Membrane Components. Journal of Investigative Dermatology, 128, E3–4.
- ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis.
  Fuhriman, J. M., Winge, M. C., Haberstock-Debic, H., Funk, J. O., Bradshaw, J. M., & Marinkovich, M. P. (2018). ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis. The Journal of Investigative Dermatology, 138(4), 864–71.
- Validity and Accuracy of a Mobile Phone Application for the Assessment of Wounds in Recessive Dystrophic Epidermolysis Bullosa.
  Nazaroff, J., Solis, D., Barriga, M., Dutt-Singkh, Y., Shufeng, L., Marinkovich, M. P., & Tang, J. Y. (2017). Validity and Accuracy of a Mobile Phone Application for the Assessment of Wounds in Recessive Dystrophic Epidermolysis Bullosa. Journal of the American Academy of Dermatology.
- Type VII Collagen Is the Major Autoantigen for Sub lamina Densa-Type Linear IgA Bullous Dermatosis
  Tsuchisaka, A., Ohara, K., Ishii, N., Nguyen, N. T., Marinkovich, M. P., & Hashimoto, T. (2015). Type VII Collagen Is the Major Autoantigen for Sub lamina Densa-Type Linear IgA Bullous Dermatosis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135(2), 626–29.
- Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB)
  Hook, K., Tolar, J., McGrath, J., Osborn, M., Keene, D., Riddle, M., … Wagner, J. (2017). Bone marrow/cord blood transplantation (BMCBT) ameliorates symptoms in some, but not all, subtypes of severe generalized junctional epidermolysis bullosa (JEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S52.
- Phase I clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
  Siprashvili, Z., Nguyen, N. T., Gorell, E., Loutit, K., Khuu, P., Furukawa, L. K., … Marinkovich, M. (2015). Phase I clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY. NATURE PUBLISHING GROUP.
- Factors That May Promote an Effective Local Research Environment
  Wang, K., Lee, C. S., Marinkovich, M. P., Chang, H. Y., Oro, A. E., & Khavari, P. A. (2016). Factors That May Promote an Effective Local Research Environment. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 136(8), 1529–31.
- Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy
  Gorell, E. S., Nguyen, N., Siprashvili, Z., Marinkovich, M. P., & Lane, A. T. (2015). Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy. BRITISH JOURNAL OF DERMATOLOGY, 173(3), 821–23.
- Bone morphogenic protein-1 inhibitors block human squamous cell carcinoma invasion in vitro
  Pai, S., Veitch, D., Ho, W., Fincher, E., Russell, A., Findell, P., & Marinkovich, M. (2001). Bone morphogenic protein-1 inhibitors block human squamous cell carcinoma invasion in vitro. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 398.
- Disruption of integrin a6b4 ligand binding through point mutation in human keratinocytes: Effects upon hemidesmosome formation and cell migration
  Russell, A. J., Ghaed, S. V., & Marinkovich, M. P. (1999). Disruption of integrin a6b4 ligand binding through point mutation in human keratinocytes: Effects upon hemidesmosome formation and cell migration. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(4), 537.
- Epidermal Rac1 hyperactivation is a key feature of human psoriasis
  Winge, M. C., Ohyama, B., Waterman, E. A., Dei, C., Ehsani-Chimeh, N., Li, W., … Marinkovich, M. P. (2014). Epidermal Rac1 hyperactivation is a key feature of human psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, S18.
- Therapy for junctional epidermolysis bullosa: Functional assays and a grafted scid mouse animal model
  Hoffler, W. K., Nelson, C. F., Matsui, C., Marinkovich, M., Mak, L. L., & Wang, C. K. (1996). Therapy for junctional epidermolysis bullosa: Functional assays and a grafted scid mouse animal model. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 10.
- JUNCTIONAL EPIDERMOLYSIS-BULLOSA SKIN GRAFTED TO THE SCID MOUSE SHOWS PRESERVATION OF THE DISEASE PHENOTYPE
  MARINKOVICH, M. P., WOODLEY, D. T., WATANABE, G. L., JENSEN, R. A., CANTRELL, C. F., BANER, E. A., … KIM, Y. H. (1995). JUNCTIONAL EPIDERMOLYSIS-BULLOSA SKIN GRAFTED TO THE SCID MOUSE SHOWS PRESERVATION OF THE DISEASE PHENOTYPE. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 104(4), 603.
- Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression
  Horst, B. A., Russell, A., Nguyen, N., & Marinkovich, M. P. (2007). Critical domains of a6 beta 4 integrin for squamous cell carcinoma progression. MODERN PATHOLOGY, 20, 94A.
- Laminin-5 Beta 3 chain promotes epidermal carcinogenesis through type VII collagen binding and pi3k activation
  Sakai, N., Waterman, E. A., Nguyen, N. E., Horst, B. A., Veitch, D. P., Dey, C. N., … Marinkovich, M. (2006). Laminin-5 Beta 3 chain promotes epidermal carcinogenesis through type VII collagen binding and pi3k activation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 126, 24.
- Development of a mouse model for linear IgA bullous dermatosis
  Geng, P., Lin, L., Park, M., Li, N., Shumate, K., Marinkovich, M. P., … Liu, Z. (2013). Development of a mouse model for linear IgA bullous dermatosis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 133, S39.
- Antibodies to BP180 induce the release of IL-6 and IL-8 from cultured normal human keratinocytes
  Schmidt, E., Reimer, S., Kruse, N., Brocker, E. B., Marinkovich, M. P., Giudice, G., & Zillikens, D. (1999). Antibodies to BP180 induce the release of IL-6 and IL-8 from cultured normal human keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 113(3), 438.
- Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosa
  Nazaroff, J., Solis, D., Bailey-Healy, I., Barriga, M., Choi, S., Dutt-Singkh, Y., … Tang, J. Y. (2017). Validity and accuracy of a mobile phone application for the assessment of chronic wounds in recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S36.
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
  Crispin, M. K., Ko, J. M., Craiglow, B. G., Li, S., Shankar, G., Urban, J. R., … King, B. A. (2016). Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata. JCI INSIGHT, 1(15).
- Laminin/integrin expression profile in malignant melanoma
  Wong, K., Marinkovich, M. P., & Horst, B. A. (2008). Laminin/integrin expression profile in malignant melanoma. LABORATORY INVESTIGATION, 88, 103A–104A.
- Laminin 10 plays a critical role in the development of normal skin and hair follicles
  Li, J., Chen, Y., Miner, J., & Marinkovich, M. (2001). Laminin 10 plays a critical role in the development of normal skin and hair follicles. JOURNAL OF INVESTIGATIVE DERMATOLOGY. BLACKWELL SCIENCE INC.
- Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB)
  Tolar, J., McGrath, J., Osborn, M., Keene, D., Riddle, M., Hook, K., … Wagner, J. (2017). Type VII collagen (C7) expression and chimerism after bone marrow/cord blood transplantation (BMCBT) for severe generalized recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S65.
- Laminin-5 inhibits keratinocyte motility
  OToole, E. A., Marinkovich, M. P., Shervin, N., & Woodley, D. T. (1996). Laminin-5 inhibits keratinocyte motility. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 98.
- Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
  Siprashvili, Z., Nguyen, N., Gorell, E., Loutit, K., Dutt-Singkh, Y., Nazaroff, J., … Marinkovich, M. (2017). Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Durable and efficient corrective keratin 14 gene therapy in recessive epidermolysis bullosa simplex (EBS)
  Pereira, P., Bruckner-Tuderman, L., Zabel, B., & Marinkovich, M. P. (1999). Durable and efficient corrective keratin 14 gene therapy in recessive epidermolysis bullosa simplex (EBS). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 112(4), 640.
- The role of collagen XVII in ras-driven human epidermal tumorigenesis
  Makino, T., Ngyun, N. T., Chen, C. H., Shimizu, T., Rizzo, A. C., & Marinkovich, M. P. (2007). The role of collagen XVII in ras-driven human epidermal tumorigenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 127, S24.
- Role of tyrosine kinase in endothelial cell migration and angiogenesis
  Zhou, L., Marinkovich, M., & Karasek, M. (2001). Role of tyrosine kinase in endothelial cell migration and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 392.
- Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using EB-101 (COL7A1 gene-corrected autologous keratinocytes)
  Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Dutt-Singkh, Y., Nazaroff, J., … Marinkovich, M. P. (2017). Phase I/IIa clinical trial for recessive dystrophic epidermolysis bullosa using EB-101 (COL7A1 gene-corrected autologous keratinocytes). HUMAN GENE THERAPY. MARY ANN LIEBERT, INC.
- Integrin alpha 6 beta 4 ligation controls keratinocyte morphology and chemotaxis through opposing stimulation of the small GTPases, Rac and Rho
  Russell, A., Fincher, E., Vela, Smith, R., & Marinkovich, M. (2001). Integrin alpha 6 beta 4 ligation controls keratinocyte morphology and chemotaxis through opposing stimulation of the small GTPases, Rac and Rho. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 117(2), 477.
- Phase 1 clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa
  Siprashvili, Z., Nguyen, N. T., Gorell, E., Khuu, P., Furukawa, L., Lorenz, H. P., … Lane, A. T. (2014). Phase 1 clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. NATURE PUBLISHING GROUP.
- Deletion of dermal integrin beta-1 leads to adhesion, but not hair follicle morphogenesis, defects
  DeRouen, M. C., Marinkovich, M. P., & Oro, A. E. (2010). Deletion of dermal integrin beta-1 leads to adhesion, but not hair follicle morphogenesis, defects. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 130, S104.
- Phenotypic reversion of alpha 3-deficient human keratinocytes and functional studies of laminin 5
  Fincher, E. F., Russell, A. J., & Marinkovich, M. P. (2000). Phenotypic reversion of alpha 3-deficient human keratinocytes and functional studies of laminin 5. MOLECULAR BIOLOGY OF THE CELL, 11, 391A–392A.
- Role of laminin-10 in hair development
  Gao, J., Chen, C., Nguyen, N. T., Leopold, P. L., Crystal, R. G., Miner, J. H., … Marinkovich, M. P. (2004). Role of laminin-10 in hair development. JOURNAL OF INVESTIGATIVE DERMATOLOGY. BLACKWELL PUBLISHING INC.
- Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015
  Choi, S., Solis, D., Nazaroff, J., Bailey-Healy, I., Barriga, M., Dutt-Singkh, Y., … Tang, J. Y. (2017). Quality of life in recessive dystrophic epidermolysis bullosa: The AltaVoice patient registry, 2012-2015. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S38.
- Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa
  Solis, D., Nazaroff, J., Dutt-Singkh, Y., Choi, S., Barriga, M., Bailey-Healy, I., … Tang, J. Y. (2017). Natural history of chronic wounds in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S37.
- Molecular mechanisms of hypoxia-driven keratinocyte motility
  OToole, E. A., Peavey, C., Marinkovich, M. P., Furthmayr, H., Mustoe, T., & Woodley, D. T. (1996). Molecular mechanisms of hypoxia-driven keratinocyte motility. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 106(4), 141.
- CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES
  Koller, M., Flanagan, K., Skov, M., Goldblum, R., Griffith, S. G., Barbour, R. M., … Ness, D. (2016). CLINICAL AND PRECLINICAL ASSESSMENT OF THE ANTI-MCAM MONOCLONAL ANTIBODY PRX003, A POTENTIAL NOVEL TREATMENT FOR TH17-MEDIATED INFLAMMATORY DISEASES. ANNALS OF THE RHEUMATIC DISEASES, 75, 134.
- NC1 domain of type VII (anchoring fibril) collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats.
  Chen, M., Marinkovich, M. P., Jones, J. C., O'Toole, E. A., Li, Y. Y., & Woodley, D. T. (1998). NC1 domain of type VII (anchoring fibril) collagen binds to the beta 3 chain of laminin 5 via a unique subdomain within the fibronectin-like repeats. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 110(4), 496.
- A novel therapeutic inhibits Rac1 mediated invasion and metastasis in a newly described in vivo model of human melanoma
  Winge, M. C., Kovalski, J., Nguyen, N. T., Wu, D., Zehnder, A., Khavari, P., & Marinkovich, M. (2015). A novel therapeutic inhibits Rac1 mediated invasion and metastasis in a newly described in vivo model of human melanoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 135, S71.
- Attenuated netrin-1 receptor mediated regulation of tiam1 is required for rac1 mutant melanoma progression
  Winge, M. C. G., Kovalski, J., Nguyen, N. T., Wu, D., Zehnder, A., Khavari, P. A., & Marinkovich, M. (2017). Attenuated netrin-1 receptor mediated regulation of tiam1 is required for rac1 mutant melanoma progression. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S139.
- Laminin 10 in wound re-epithelialization and angiogenesis
  Li, J., Kirsner, R. S., Marinkovich, M. P., Miner, J. H., & Zhang, Y. (2002). Laminin 10 in wound re-epithelialization and angiogenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 119(1), 233.
- LAMININ-5 INHIBITS KERATINOCYTE MOTILITY
  OTOOLE, E. A., MARINKOVICH, M. P., YURKO, M. A., & WOODLEY, D. T. (1995). LAMININ-5 INHIBITS KERATINOCYTE MOTILITY. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 105(6), 871.
- Loss of the laminin-332 alpha 3IIIa domain impairs keratinocyte migration in vitro
  Wang, J. Y., Lakshmireddy, H. K. D., & Marinkovich, M. P. (2014). Loss of the laminin-332 alpha 3IIIa domain impairs keratinocyte migration in vitro. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 134, S87.
- Laminin/Integrin expression profile in malignant melanoma
  Wong, K., Marinkovich, M. P., & Horst, B. A. (2008). Laminin/Integrin expression profile in malignant melanoma. MODERN PATHOLOGY, 21, 103A–104A.
- ITK and RLK inhibitor improves skin disease in a psoriatic mouse model
  Fuhriman, J. M., Winge, M. C. G., Haberstock-Debic, H., Funk, J. O., Bradshaw, M., & Marinkovich, M. (2017). ITK and RLK inhibitor improves skin disease in a psoriatic mouse model. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 137(5), S120.
- Laminin 10 in the angiogenesis and invasion of squamous cell carcinoma
  Li, J., Zhang, Y., Romagosa, R., Saghari, S., Elgart, G., Miner, J. H., … Nouri, K. (2005). Laminin 10 in the angiogenesis and invasion of squamous cell carcinoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 124(4), A21.
- Targeting pathogenic interactions between Rac1 and NCK1 in psoriasis
  Winge, M. C. G., Nasrallah, M., Fuhriman, J. M., Ramanathan, M., Azameera, A., Nguyen, N., … Marinkovich, M. (2018). Targeting pathogenic interactions between Rac1 and NCK1 in psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Successful in vivo COL7A1 gene delivery and correction of recessive dystrophic epidermolysis bullosa (RDEB) skin using an off the shelf HSV-1 vector (KB103)
  Gurevich, I., Agarwal, P., Dolorito, J., Prisco, M., O'Malley, M., Regula, L., … Marinkovich, M. (2018). Successful in vivo COL7A1 gene delivery and correction of recessive dystrophic epidermolysis bullosa (RDEB) skin using an off the shelf HSV-1 vector (KB103). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S129.
- Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment
  Solis, D., Nazaroff, J., Dutt-Singkh, Y., Choi, S., Barriga, M., Li, S., … Tang, J. (2018). Defining chronic wound types in recessive dystrophic epidermolysis bullosa patients for clinical outcome assessment. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S97.
- Measurement of skin adherence in recessive dystrophic epidermolysis bullosa patients
  Nazaroff, J., Li, S., Lane, A., Marinkovich, M., & Tang, J. (2018). Measurement of skin adherence in recessive dystrophic epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S102.
- 50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durability
  Dutt-Singkh, Y., Barriga, M., Nazaroff, J., Solis, D., Li, S., Marinkovich, M., & Tang, J. (2018). 50% wound healing correlates with RDEB patient reported outcomes in pain, itch and skin durability. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S56.
- A phase 1/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB)
  Marinkovich, M., Lane, A., Sridhar, K., Keene, D., Malyala, A., & Maslowski, J. (2018). A phase 1/2 study of genetically-corrected, collagen VII expressing autologous human dermal fibroblasts injected into the skin of patients with recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(5), S100.
- A new deletion mutation sheds light on laminin-332 biology.
  Marinkovich, M. P. (2018). A new deletion mutation sheds light on laminin-332 biology. The British Journal of Dermatology, 178(6), 1245.
- CyTOF analysis allows characterization of Axl-Expressing Dendritic cells in healthy human donors
  Leylek, R., Alcantara-Hernandez, M., Wagar, L. E., Engleman, E. G., Marinkovich, M. P., Davis, M. M., … Idoyaga, J. (2018). CyTOF analysis allows characterization of Axl-Expressing Dendritic cells in healthy human donors. EUROPEAN JOURNAL OF IMMUNOLOGY, 48, 29.
- A high-dimensional phenotypic map of human Dendritic cells paves the way for therapeutics
  Alcantara-Hernandez, M., Leylek, R., Wagar, L. E., Engleman, E. G., Keler, T., Marinkovich, M. P., … Idoyaga, J. (2018). A high-dimensional phenotypic map of human Dendritic cells paves the way for therapeutics. EUROPEAN JOURNAL OF IMMUNOLOGY, 48, 25–26.
- Phase I / II Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using EB-101 (COL7A1 Gene-Corrected Autologous Keratinocytes)
  Tang, J. Y., Marinkovich, M. P., Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., … Lane, A. T. (2018). Phase I / II Clinical Trial for Recessive Dystrophic Epidermolysis Bullosa Using EB-101 (COL7A1 Gene-Corrected Autologous Keratinocytes). MOLECULAR THERAPY. CELL PRESS.
- Measurement of Skin Adhesion in Recessive Dystrophic Epidermolysis Bullosa Patients.
  Nazaroff, J., Manoukian, M., Barriga, M., Lane, A., Marinkovich, M. P., & Tang, J. Y. (2018). Measurement of Skin Adhesion in Recessive Dystrophic Epidermolysis Bullosa Patients. Journal of the American Academy of Dermatology.
- Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts.
  Murrell, D. F., Pena, S., Joly, P., Marinovic, B., Hashimoto, T., Diaz, L. A., … Werth, V. P. (2018). Diagnosis and Management of Pemphigus: recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology.
- Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis.
  Baumer, Y., Ng, Q., Sanda, G. E., Dey, A. K., Teague, H. L., Sorokin, A. V., … Mehta, N. N. (2018). Chronic skin inflammation accelerates macrophage cholesterol crystal formation and atherosclerosis. JCI Insight, 3(1).
- A new deletion mutation sheds light on laminin-332 biology
  Marinkovich, M. P. (2018). A new deletion mutation sheds light on laminin-332 biology. BRITISH JOURNAL OF DERMATOLOGY, 178(6), 1245.
- ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis
  Fuhriman, J. M., Winge, M. C. G., Haberstock-Debic, H., Funk, J. O., Bradshaw, J. M., & Marinkovich, M. P. (2018). ITK and RLK Inhibitor PRN694 Improves Skin Disease in Two Mouse Models of Psoriasis. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 138(4), 864–71.
- Gene Therapy for Epidermolysis Bullosa.
  Marinkovich, M. P., & Tang, J. Y. (2019). Gene Therapy for Epidermolysis Bullosa. The Journal of Investigative Dermatology.
- Genetically corrected autologous keratinocyte epidermal grafts improve wound healing and patient reported outcomes in patients with recessive dystrophic epidermolysis bullosa
  Eichstadt, S., Barriga, M., Teng, C., Nguyen, N. T., Gorell, E., Siprashvili, Z., … Tang, J. (2019). Genetically corrected autologous keratinocyte epidermal grafts improve wound healing and patient reported outcomes in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Natural history of wounds in patients with recessive dystrophic epidermolysis bullosa
  Teng, C., Solis, D., Tang, J., Barriga, M., & Marinkovich, M. P. (2019). Natural history of wounds in patients with recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S43.
- The use of human skin equivalents to evaluate the effectivity of QR-313, an antisense oligonucleotide, in gel formulation
  Hogervorst, M., van Berkel, M., Oort, C., Marinkovich, M. P., Keene, D., Ritsema, T., … Haisma, I. (2019). The use of human skin equivalents to evaluate the effectivity of QR-313, an antisense oligonucleotide, in gel formulation. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S64.
- First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial
  Marinkovich, M. P., Sridhar, K., Gurevich, I., Ponakala, A., Boddu, S., Keene, D., … Krishnan, S. (2019). First in human use of a novel in vivo gene therapy to successfully correct recessive dystrophic epidermolysis bullosa (RDEB) skin: Results of a phase 1/2 placebo controlled trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(5), S66.
- Gene Therapy for Epidermolysis Bullosa
  Marinkovich, M. P., & Tang, J. Y. (2019). Gene Therapy for Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 139(6), 1221–26.
- Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
  Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N. T., Siprashvili, Z., … Tang, J. Y. (2019). Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight, 4(19).
- Epidermolysis bullosa with pyloric atresia consistently demonstrates concurrent low intra-basal epidermal and lamina lucida cleavage planes: a survey of six cases.
  Wang, J. Y., Marinkovich, M. P., & Rieger, K. E. (2019). Epidermolysis bullosa with pyloric atresia consistently demonstrates concurrent low intra-basal epidermal and lamina lucida cleavage planes: a survey of six cases. Journal of the European Academy of Dermatology and Venereology : JEADV.
- From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB)
  Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (2019). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 12, 933–42.
- From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
  Eichstadt, S., Tang, J. Y., Solis, D. C., Siprashvili, Z., Marinkovich, M. P., Whitehead, N., … Sarin, K. Y. (2019). From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB). Clinical, Cosmetic and Investigational Dermatology, 12, 933–942.
- Diagnosis and management of pemphigus: Recommendations of an international panel of experts
  Murrell, D. F., Pena, S., Joly, P., Marinovic, B., Hashimoto, T., Diaz, L. A., … Werth, V. P. (2020). Diagnosis and management of pemphigus: Recommendations of an international panel of experts. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 82(3), 575-+.
- Patient Reported Outcomes and Quality of Life in Recessive Dystrophic Epidermolysis Bullosa: A Global Cross-sectional Survey.
  Eng, V. A., Solis, D. C., Gorell, E. S., Choi, S., Nazaroff, J., Li, S., … Tang, J. Y. (2020). Patient Reported Outcomes and Quality of Life in Recessive Dystrophic Epidermolysis Bullosa: A Global Cross-sectional Survey. Journal of the American Academy of Dermatology.
- Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility.
  Has, C., Bauer, J. W., Bodemer, C., Bolling, M. C., Bruckner-Tuderman, L., Diem, A., … Mellerio, J. E. (2020). Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. The British Journal of Dermatology.
- Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts.
  Murrell, D. F., Lucky, A. W., Salas-Alanis, J. C., Woodley, D. T., Palisson, F., Natsuga, K., … Martinez, A. E. (2020). Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology.
- Neutrophils are critical in linear IgA bullous dermatosis in mice
  Li, N., Burette, S., Jing, K., Mulligan, E., Yanik, J., Yang, B., … Liu, Z. (2020). Neutrophils are critical in linear IgA bullous dermatosis in mice. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S10.
- Type VII collagen NC2 domain expression differentiates severe from milder recessive dystrophic epidermolysis bullosa subtypes
  Ponakala, A., Yenamandra, V. K., Teng, C. E., Barriga, M., Dolorito, J., Gorell, E., … Marinkovich, M. P. (2020). Type VII collagen NC2 domain expression differentiates severe from milder recessive dystrophic epidermolysis bullosa subtypes. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
- Premature thymic involution and oropharyngeal blistering cause early lethality in generalized severe junctional epidermolysis bullosa
  Yenamandra, V. K., Dolorito, J., Gurevitch, I., Godoy, E., Casey, K., & Marinkovich, M. P. (2020). Premature thymic involution and oropharyngeal blistering cause early lethality in generalized severe junctional epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Topical QR-313, an Antisense Oligonucleotide, in the Treatment of Dystrophic Epidermolysis Bullosa
  Marinkovich, M. P., Sridhar, K., Karkala, V., Yenamandra, V. K., Gurevitch, I., Dolorito, J., … Landy, H. (2020). Topical QR-313, an Antisense Oligonucleotide, in the Treatment of Dystrophic Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
- In vivo correction of recessive dystrophic epidermolysis bullosa (RDEB) by direct cutaneous COL7A1 gene replacement: Results of a phase 1-2 trial
  Marinkovich, M. P., Vinzant, S., Karkala, V., Sridhar, K., Gurevitch, I., Dolorito, J., … Krishnan, S. (2020). In vivo correction of recessive dystrophic epidermolysis bullosa (RDEB) by direct cutaneous COL7A1 gene replacement: Results of a phase 1-2 trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S37.
- Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey
  Gorell, E., Eng, V., Solis, D., Choi, S., Nazaroff, J., Li, S., … Tang, J. (2020). Larger wounds in recessive dystrophic epidermolysis bullosa patients associated with worse quality of life: Results of a global cross-sectional survey. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 140(7), S34.
- Classification of Two Distinct Wound Types in Recessive Dystrophic Epidermolysis Bullosa: A Retrospective and Cohort Natural History Study.
  Solis, D. C., Teng, C., Gorell, E. S., Barriga, M., Nazaroff, J., Li, S., … Tang, J. Y. (2020). Classification of Two Distinct Wound Types in Recessive Dystrophic Epidermolysis Bullosa: A Retrospective and Cohort Natural History Study. Journal of the American Academy of Dermatology.
- Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa.
  Fuentes, I., Guttmann-Gruber, C., Tockner, B., Diem, A., Klausegger, A., Cofré-Araneda, G., … South, A. P. (2020). Cells from discarded dressings differentiate chronic from acute wounds in patients with Epidermolysis Bullosa. Scientific Reports, 10(1), 15064.
- QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study.
  Bornert, O., Hogervorst, M., Nauroy, P., Bischof, J., Swildens, J., Athanasiou, I., … Nystrom, A. (2020). QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study. The Journal of Investigative Dermatology.
- Epidermolysis bullosa.
  Bardhan, A., Bruckner-Tuderman, L., Chapple, I. L., Fine, J.-D., Harper, N., Has, C., … Heagerty, A. H. (2020). Epidermolysis bullosa. Nature Reviews. Disease Primers, 6(1), 78.
- RESEARCH UPDATE (GENE AND PROTEIN)
  Marinkovich, M. P. (2020). RESEARCH UPDATE (GENE AND PROTEIN). ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- A PHASE 1/2 STUDY OF GENETICALLY-CORRECTED, COLLAGEN VII EXPRESSING AUTOLOGOUS HUMAN DERMAL FIBROBLASTS INJECTED INTO THE SKIN OF PATIENTS WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB)
  Marinkovich, M. P., Lane, A., Sridhar, K., Keene, D., Malyala, A., Spellman, M., & Maslowski, J. (2020). A PHASE 1/2 STUDY OF GENETICALLY-CORRECTED, COLLAGEN VII EXPRESSING AUTOLOGOUS HUMAN DERMAL FIBROBLASTS INJECTED INTO THE SKIN OF PATIENTS WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB). ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- UNDERSTANDING OCULAR DISEASE IN THE DEB MOUSE MODEL: CHALLENGES OF ASYMMETRY AND SURVIVAL
  Chen, V. M., Richey, L., Esmail, M., Shelke, R., Cao, Z., Panjwani, N., & Marinkovich, M. P. (2020). UNDERSTANDING OCULAR DISEASE IN THE DEB MOUSE MODEL: CHALLENGES OF ASYMMETRY AND SURVIVAL. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- RESULTS FROM A PHASE I/II STUDY OF A TOPICAL GENE THERAPY (BERCOLAGENE TELSERPAVEC, B-VEC) IN PATIENTS WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB)
  Marinkovich, M. P., Vinzant, S., Agarwal, P., & Krishna, S. (2020). RESULTS FROM A PHASE I/II STUDY OF A TOPICAL GENE THERAPY (BERCOLAGENE TELSERPAVEC, B-VEC) IN PATIENTS WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA (RDEB). ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- PHASE 1/2A CLINICAL TRIAL OF GENE-CORRECTED AUTOLOGOUS CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA
  Gorell, E., Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N., … Tang, J. Y. (2020). PHASE 1/2A CLINICAL TRIAL OF GENE-CORRECTED AUTOLOGOUS CELL THERAPY FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- GENE THERAPY FOR RDEB (EX VIVO VS IN VIVO)
  Marinkovich, M. P. (2020). GENE THERAPY FOR RDEB (EX VIVO VS IN VIVO). ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- IMMUNE CELL PROFILING OF WOUNDS FROM EPIDERMOLYSIS BULLOSA PATIENTS
  Fuentes, I., Guttmann-Gruber, C., Tockner, B., Diem, A., Klausegger, A., Cofre-Araneda, G., … South, A. P. (2020). IMMUNE CELL PROFILING OF WOUNDS FROM EPIDERMOLYSIS BULLOSA PATIENTS. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- CLASSIFICATION OF TWO DISTINCT WOUND TYPES IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA: A NATURAL HISTORY STUDY
  Teng, C. E., Solis, D. C., Barriga, M., Li, S., Marinkovich, M. P., & Tang, J. Y. (2020). CLASSIFICATION OF TWO DISTINCT WOUND TYPES IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA: A NATURAL HISTORY STUDY. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- COSTS AND ACCESSIBILITY
  Marinkovich, M. P. (2020). COSTS AND ACCESSIBILITY. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- RELATIONSHIPS BETWEEN WOUND SIZE, CLINICAL MANIFESTATIONS, AND QUALITY OF LIFE IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA: A GLOBAL CROSS-SECTIONAL SURVEY
  Gorell, E. S., Eng, V., Solis, D., Choi, S., Nazaroff, J., de Souza, M., … Tang, J. Y. (2020). RELATIONSHIPS BETWEEN WOUND SIZE, CLINICAL MANIFESTATIONS, AND QUALITY OF LIFE IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA: A GLOBAL CROSS-SECTIONAL SURVEY. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- RECOMBINANT HUMAN COLLAGEN VII DECREASES MARKERS OF FIBROSIS AFTER CORNEAL ABRASION IN MICE WITH EPIDERMOLYSIS BULLOSA
  Chen, V. M., Shelke, R., Gipson, I., Kumar-Singh, R., Panjwani, N., Cao, Z., … Marinkovich, M. P. (2020). RECOMBINANT HUMAN COLLAGEN VII DECREASES MARKERS OF FIBROSIS AFTER CORNEAL ABRASION IN MICE WITH EPIDERMOLYSIS BULLOSA. ACTA DERMATO-VENEREOLOGICA. ACTA DERMATO-VENEREOLOGICA.
- Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa.
  Solis, D. C., Gorell, E. S., Teng, C., Barriga, M., Nazaroff, J., Li, S., … Tang, J. Y. (2021). Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology.
- A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa.
  Tang, J. Y., Marinkovich, M. P., Lucas, E., Gorell, E., Chiou, A., Lu, Y., … Rudin, D. (2021). A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases, 16(1), 175.
- Patient reported outcomes following EB-101 treatment of recessive dystrophic epidermolysis bullosa (rdeb) wounds showed durable wound healing and reduction in disease burden
  Tang, J., Marinkovich, M., Barriga, M., Bailey, I., Harris, N., & Rudin, D. (2021). Patient reported outcomes following EB-101 treatment of recessive dystrophic epidermolysis bullosa (rdeb) wounds showed durable wound healing and reduction in disease burden. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Assessment of safety in repeat dosing of an in vivo topical gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) in a phase I/II trial
  Marinkovich, M., Forte, S., Oliver, S., Dolorito, J., Sridhar, K., Liu, H., … Krishnan, S. (2021). Assessment of safety in repeat dosing of an in vivo topical gene therapy for the treatment of recessive dystrophic epidermolysis bullosa (RDEB) in a phase I/II trial. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Measurement of skin adhesion in recessive dystrophic epidermolysis bullosa patients
  Nazaroff, J., Manoukian, M., Barriga, M., Lane, A., Marinkovich, M. P., & Tang, J. Y. (2021). Measurement of skin adhesion in recessive dystrophic epidermolysis bullosa patients. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 85(2), 491–492.
- Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey.
  Fulchand, S., Harris, N., Li, S., Barriga, M., Gorell, E., De Souza, M., … Tang, J. Y. (2021). Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey. Pediatric Dermatology.
- In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial.
  Gurevich, I., Agarwal, P., Zhang, P. P., Dolorito, J. A., Oliver, S., Liu, H., … Marinkovich, M. P. (2022). In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nature Medicine.
- Characterization of DSG3-CAART Cells Prior to & Following Adoptive Transfer in Mucosal Pemphigus Vulgaris
  Basu, S., Volkov, J. S., Chang, D., Nunez, D., Hoffman, K., Manfredo-Vieira, S., … Payne, A. (2022). Characterization of DSG3-CAART Cells Prior to & Following Adoptive Transfer in Mucosal Pemphigus Vulgaris. MOLECULAR THERAPY. CELL PRESS.
- The Treatment of Wounds Associated with Recessive Dystrophic Epidermolysis Bullosa with Local Injections of Gene-Corrected, Collagen VII-Expressing Autologous Human Dermal Fibroblasts
  Marinkovich, M. P., Sridhar, K. J., Bagci, I. S., Dolorito, J. A. M., Keene, D. R., Yonchek, M., … Spellman, M. C. (2022). The Treatment of Wounds Associated with Recessive Dystrophic Epidermolysis Bullosa with Local Injections of Gene-Corrected, Collagen VII-Expressing Autologous Human Dermal Fibroblasts. MOLECULAR THERAPY. CELL PRESS.
- A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data
  Chang, D. J., Basu, S., Porter, D., Abedi, M., Weng, W.-K., Micheletti, R., … Payne, A. S. (2022). A Phase 1 Trial of Targeted DSG3-CAART Cell Therapy in Mucosal-Dominant Pemphigus Vulgaris (mPV) Patients: Early Cohort Data. MOLECULAR THERAPY. CELL PRESS.
- Localized CO2 laser treatment of a recalcitrant oral ulceration in pemphigus vulgaris
  Chainani-Wu, N., Gopal-Murthy, V., Wu, A., & Marinkovich, M. P. (2022). Localized CO2 laser treatment of a recalcitrant oral ulceration in pemphigus vulgaris. CLINICAL ADVANCES IN PERIODONTICS.
- Genotype-phenotype associations in recessive dystrophic epidermolysis bullosa (RDEB)
  So, J., Harris, N., Fulchand, S., Gorell, E., Nazaroff, J., Yenamandra, V., … Tang, J. (2022). Genotype-phenotype associations in recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- GEM-3: phase 3 safety and immunogenicity results of beremagene geperpavec (B-VEC), an investigational, topical gene therapy for dystrophic epidermolysis bullosa (DEB)
  Marinkovich, M., Gonzalez, M., Guide, S., Bagci, I. S., Chitra, S., Agostini, B., … Krishnan, S. (2022). GEM-3: phase 3 safety and immunogenicity results of beremagene geperpavec (B-VEC), an investigational, topical gene therapy for dystrophic epidermolysis bullosa (DEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- A phase 1 trial of DSG3-CAART cells in mucosal-dominant pemphigus vulgaris (mPV) patients: Preliminary data
  Chang, D. J., Basu, S., Micheletti, R., Maverakis, E., Marinkovich, M., Porter, D. L., … Payne, A. S. (2022). A phase 1 trial of DSG3-CAART cells in mucosal-dominant pemphigus vulgaris (mPV) patients: Preliminary data. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.
  So, J. Y., Nazaroff, J., Iwummadu, C. V., Harris, N., Gorell, E. S., Fulchand, S., … Chiou, A. S. (2022). Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases, 17(1), 377.
- Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
  Guide, S. V., Gonzalez, M. E., Bagci, I. S., Agostini, B., Chen, H., Feeney, G., … Marinkovich, M. P. (2022). Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa. The New England Journal of Medicine, 387(24), 2211–2219.
- Characterization of DSG3-CAART cells prior to & following adoptive transfer in mucosal Pemphigus Vulgaris
  Basu, S., Volkov, J., Nunez, D., Fouch, M., Stadanlick, J., Binder, G., … Payne, A. S. (2022). Characterization of DSG3-CAART cells prior to & following adoptive transfer in mucosal Pemphigus Vulgaris. HUMAN GENE THERAPY. MARY ANN LIEBERT, INC.
- Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-? paraproteinemia in an 81-year-old woman.
  Chau, T., Wu, J., Kahn, B., Elco, C., Marinkovich, M. P., Rieger, K. E., … Firoz, E. F. (2023). Mixed IgM- and IgA-mediated epidermolysis bullosa acquisita associated with IgM-? paraproteinemia in an 81-year-old woman. JAAD Case Reports, 34, 7–9.
- Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient management.
  Mellerio, J. E., Kiritsi, D., Marinkovich, M. P., Haro, N. R., Badger, K., Arora, M., … Martinez, A. E. (2023). Mapping the burden of severe forms of epidermolysis bullosa - Implications for patient management. JAAD International, 11, 224–232.
- Anti-NC16A IgA from linear IgA bullous dermatosis patients induce neutrophil-dependent subepidermal blistering in mice.
  Jing, K., Jordan, T. J., Li, N., Burette, S., Yang, B., Marinkovich, M. P., … Liu, Z. (2023). Anti-NC16A IgA from linear IgA bullous dermatosis patients induce neutrophil-dependent subepidermal blistering in mice. The Journal of Investigative Dermatology.
- Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa.
  Orlowski, G. M., Amano, S. U., Flanagan, K. E., Rieger, K. E., Marinkovich, M. P., & Wiss, K. (2023). Treatment With Ataluren for Wound Healing and Health Complications in a Patient With Junctional Epidermolysis Bullosa. JAMA Dermatology.
- Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa
  Pathmarajah, P., So, J., Nazaroff, J., Harris, N., Marinkovich, M. P., & Tang, J. Y. (2023). Functional genotype-phenotype associations in recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Results from VIITAL: A phase 3, randomized, intrapatient-controlled trial of an investigational collagen type VII gene-corrected autologous cell therapy, EB-101, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)
  Tang, J. Y., Marinkovich, M. P., Wiss, K., McCarthy, D., Truesdale, A., Chiou, A. S., … Grachev, I. (2023). Results from VIITAL: A phase 3, randomized, intrapatient-controlled trial of an investigational collagen type VII gene-corrected autologous cell therapy, EB-101, for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Neutrophil elastase is critical in linear IgA bullous dermatosis in mice
  Li, N., Burette, S., Yang, B., Marinkovich, M. P., Diaz, L., Googe, P., … Liu, Z. (2023). Neutrophil elastase is critical in linear IgA bullous dermatosis in mice. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Long term use of topical beremagene geperpavec (B-VEC) in two patients with dystrophic epidermolysis bullosa
  Bagci, I., Momin, N., Agostini, B., Chen, H., Feeney, G., Steimer, M., … Marinkovich, M. P. (2023). Long term use of topical beremagene geperpavec (B-VEC) in two patients with dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer.
  Chang, J., Saraswathibhatla, A., Song, Z., Varma, S., Sanchez, C., Alyafei, N. H., … Chaudhuri, O. (2023). Cell volume expansion and local contractility drive collective invasion of the basement membrane in breast cancer. Nature Materials.
- Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
  Paller, A. S., Guide, S. V., Ayala, D., Gonzalez, M. E., Lucky, A. W., Bagci, I. S., & Marinkovich, M. P. (2024). Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa. The Journal of Dermatological Treatment, 35(1), 2350232.
- Functional Genotype-Phenotype Associations in Recessive Dystrophic Epidermolysis Bullosa.
  So, J. Y., Nazaroff, J., Yenamandra, V. K., Gorell, E. S., Harris, N., Fulchand, S., … Tang, J. Y. (2024). Functional Genotype-Phenotype Associations in Recessive Dystrophic Epidermolysis Bullosa. Journal of the American Academy of Dermatology.
- Collagen VII's Dual Mesenchymal and Epithelial Origins: Implications for Molecular Corrective Therapies.
  Bagci, I. S., Gurevich, I., Dolorito, J. A., Tripathi, P., Momin, N. S., Sun, A., … Marinkovich, M. P. (2024). Collagen VII's Dual Mesenchymal and Epithelial Origins: Implications for Molecular Corrective Therapies. The Journal of Investigative Dermatology.
- Wound behavior in dystrophic epidermolysis bullosa: A retrospective natural history case series.
  La, T., Chen, H., Chen, S., Bagci, I. S., Sridhar, K., Momin, N., … Marinkovich, M. P. (2024). Wound behavior in dystrophic epidermolysis bullosa: A retrospective natural history case series. Journal of the American Academy of Dermatology.
- A tyrosine residue on ß4 integrin endodomain plays a key role in epidermal tumorigenesis
  Tripathi, P., Marinkovich, M., & Kariya, Y. (2024). A tyrosine residue on ß4 integrin endodomain plays a key role in epidermal tumorigenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Lateral association of anchoring fibrils in the absence of anti-parallel dimer formation in two dystrophic epidermolysis bullosa patients
  Momin, N., Bagci, I., Dolorito, J. M., Tufa, S., Tripathi, P., Sridhar, K. J., … Marinkovich, M. (2024). Lateral association of anchoring fibrils in the absence of anti-parallel dimer formation in two dystrophic epidermolysis bullosa patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- 11-year safety profile of genetically engineered autologous cell therapy in recessive dystrophic epidermolysis bullosa
  Gaona, R. V., Gorell, E. S., Marinkovich, M., Chiou, A., Wiss, K., Eid, E., … Tang, J. Y. (2024). 11-year safety profile of genetically engineered autologous cell therapy in recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Immune reactions in dystrophic epidermolysis bullosa patients following gene therapy
  Bagci, I., Tripathi, P., Sun, A., Dolorito, J. M., Sridhar, K. J., Momin, N., & Marinkovich, M. (2024). Immune reactions in dystrophic epidermolysis bullosa patients following gene therapy. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa
  Eid, E., Pathmarajah, P., Nazaroff, J., So, J., Mittal, V., Gaona, R. V., … Tang, J. Y. (2024). Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation.
  Winge, M. C., Nasrallah, M., Jackrazi, L. V., Guo, K. Q., Fuhriman, J. M., Szafran, R., … Marinkovich, M. P. (2024). Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation. Science Translational Medicine, 16(777), eade5915.
- Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa.
  Pathmarajah, P., Eid, E., Nazaroff, J., So, J., Mittal, V., Harris, N., … Tang, J. Y. (2025). Functional genotype classification groups distinguish disease severity in recessive dystrophic epidermolysis bullosa. The British Journal of Dermatology.
- Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa.
  Marinkovich, M. P., Paller, A. S., Guide, S. V., Gonzalez, M. E., Lucky, A. W., Bagci, I. S., … Krishnan, S. M. (2025). Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. American Journal of Clinical Dermatology.
- Correlative findings following DSG3-CAART infusion with and without preconditioning in patients with Pemphigus Vulgaris (DesCAARTes study)
  Nunez, D., Volkov, J. R., Fouch, M., Stadanlick, J., Schmitt, C., Miller, C. M., … Basu, S. (2024). Correlative findings following DSG3-CAART infusion with and without preconditioning in patients with Pemphigus Vulgaris (DesCAARTes study). HUMAN GENE THERAPY. MARY ANN LIEBERT, INC.
- Correlative findings following DSG3-CAART infusion with and without preconditioning in patients with Pemphigus Vulgaris (DesCAARTesTM trial)
  Nunez, D., Volkov, J. R., Thompson, D., Stadanlick, J., Werner, M., Cicarelli, J., … Basu, S. (2025). Correlative findings following DSG3-CAART infusion with and without preconditioning in patients with Pemphigus Vulgaris (DesCAARTesTM trial). HUMAN GENE THERAPY. MARY ANN LIEBERT, INC.
- Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa.
  Marinkovich, M. P., Paller, A. S., Guide, S. V., Gonzalez, M. E., Lucky, A. W., Bagci, I. S., … Krishnan, S. M. (2025). Correction to: Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa. American Journal of Clinical Dermatology.
- Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial.
  Tang, J. Y., Marinkovich, M. P., Wiss, K., McCarthy, D., Truesdale, A., Chiou, A. S., … Moore, A. J. (2025). Prademagene zamikeracel for recessive dystrophic epidermolysis bullosa wounds (VIITAL): a two-centre, randomised, open-label, intrapatient-controlled phase 3 trial. Lancet (London, England).
- 11-year Safety Profile of Pz-cel, an Autologous Cell-based Gene Therapy in Recessive Dystrophic Epidermolysis Bullosa
  Gorell, E., Gaona, R. V., Marinkovich, M. P., Chiou, A., Wiss, K., Eid, E., … Tang, J. (2025). 11-year Safety Profile of Pz-cel, an Autologous Cell-based Gene Therapy in Recessive Dystrophic Epidermolysis Bullosa. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Clinical characteristics of recessive dystrophic epidermolysis bullosa patients with collagen VII antibodies
  Truong, A., Horn, K., Levin, L., Gorell, E., Lucky, A. W., Augsburger, B., … Morel, K. (2025). Clinical characteristics of recessive dystrophic epidermolysis bullosa patients with collagen VII antibodies. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- A tyrosine residue on b4 integrin endodomain plays a key role in epidermal tumorigenesis
  Tripathi, P., Marinkovich, M., & Kariya, Y. (2025). A tyrosine residue on b4 integrin endodomain plays a key role in epidermal tumorigenesis. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- Clinical and translational data from a first-in-human study of a novel precision cellular immunotherapy (DSG3-CAART) in mucosal pemphigus vulgaris
  Payne, A. S., Nunez, D., Volkov, J., Thompson, D., Werner, M., Stadanlick, J., … Basu, S. (2025). Clinical and translational data from a first-in-human study of a novel precision cellular immunotherapy (DSG3-CAART) in mucosal pemphigus vulgaris. JOURNAL OF INVESTIGATIVE DERMATOLOGY. ELSEVIER SCIENCE INC.
- An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa.
  Lesiak, A., & Marinkovich, M. P. (2026). An evaluation of prademagene zamikeracel for the treatment of recessive dystrophic epidermolysis bullosa. Expert Opinion on Biological Therapy.
- Observations of dystrophic epidermolysis bullosa patients with collagen VII NC2 truncation provide new insights into anchoring fibril assembly.
  Momin, N. S., Bagci, I. S., Dolorito, J. A., Tufa, S. F., Tripathi, P., Sridhar, K. J., … Marinkovich, M. P. (2026). Observations of dystrophic epidermolysis bullosa patients with collagen VII NC2 truncation provide new insights into anchoring fibril assembly. Matrix Biology : Journal of the International Society for Matrix Biology.
- Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex
  Pathmarajah, P., Li, S., Mathur, M. B., Teng, J. M. C., Marinkovich, M. P., Johnson, A. N., … Chiou, A. S. (2026). Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex. JEADV CLINICAL PRACTICE.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

Specializing In

Blistering Diseases
Epidermolysis Bullosa

Practice Locations

Blistering Disease Clinic Redwood City, CA

Redwood City, CA

Blistering Disease Clinic

450 Broadway, Pavilion B 4th Fl

Redwood City , CA 94063

(650) 723-6316

More Clinic Information

Skin Cancer Program in Palo Alto Palo Alto, CA

Palo Alto, CA

Skin Cancer Program in Palo Alto

900 Blake Wilbur Dr, 3rd Fl

Palo Alto , CA 94304

(650) 498-6000

More Clinic Information

General Dermatology Clinic in Redwood City Redwood City, CA

Redwood City, CA

General Dermatology Clinic in Redwood City

450 Broadway, Pavilion B 4th Fl

Redwood City , CA 94063

(650) 723-6316

More Clinic Information

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Ratings

(7 Ratings)

Overall Rating

4.6/5

View Ratings by Category

5.0/5

Friendliness

5.0/5

Explanations

5.0/5

Listens

5.0/5

Care provider's efforts to include you in decisions about your care

4.8/5

Recommended to others

How Our Ratings Work

The Patients Ratings and comments are gathered from our Patient Satisfaction Survey and displayed in their entirety.

Patient Satisfaction Survey Disclaimer

Review Summary

Dr. Marinkovich is frequently described as an exceptional and caring professional. He is known for his excellent communication skills, genuine compassion, and for taking the time to listen to and fully understand patient concerns. His sensitivity and comforting manner create a positive doctor-patient relationship built on trust and respect.

The summary was created by AI, based on recent patient reviews. Learn more

Was this result useful to you?

Patient Reviews

(28 reviews)

amanda and the doctor were amazing

Jan 2025

•

Verified SHC Patient

Excellent Doctor. I am very please with his work with me.

Dec 2024

•

Verified SHC Patient

Excellent clinician

Nov 2024

•

Verified SHC Patient

Dr. Marankovich has the rare combination of being smart, knowledgeable, good communicator and still showing sensitivity to patients.

Apr 2024

•

Verified SHC Patient

I adore Dr. Marinkovich on so many levels. He should hold workshops on bedside manner and on building a strong doctor/patient relationship and healing care. He has such a wonderful and genuine way with people! He is the consummate professional in his field, without displaying a sense of superiority and inflexibility as many medical professionals do in the current times. Dr. Marinkovich earns his patient's trust through respect and his excellent listening skills, availability, warm and fun personality, sensitivity, calming, never treats your visit as impersonal and rushed (like herding cattle in and out), keeps and open mind to patient's interests.. He breaks the old mold of impersonal doctor patient relationships that is seen regularly and especially at more highly recognized establishment like Stanford. You, and we, are so fortunate to have Dr. Marinkovich with us through our healing journey. .

Apr 2024

•

Verified SHC Patient

I certainly will recommend to my friends

Oct 2023

•

Verified SHC Patient

I was very impressed with my visit

Sep 2023

•

Verified SHC Patient

Dr. Marinkovich is outstanding in every way.

Mar 2023

•

Verified SHC Patient

My first experience with Stanford was an excellent one. From the first call, to greetings upon arrival, to assisting staff and Dr. Marinkovich was fantastic. I would not hesitate to recommend Stanford to anyone in need of top quality care.

Dec 2022

•

Verified SHC Patient

Everyone at Stanford Medical is kind and polite.

Aug 2022

•

Verified SHC Patient

Great guy and very easy to talk to !! Explained all the questions I had !!

Aug 2022

•

Verified SHC Patient

Ve4ry Capable Dr to work with.

Mar 2022

•

Verified SHC Patient

Wow! First time at Stanford facility. Dr. Marinkovich and his staff was super attentive and listened! They also provided professional advice and follow up options as well as plans for next steps. I love it! Great first impression!

Feb 2022

•

Verified SHC Patient

Yes, I recommend the doctor.

Oct 2021

•

Verified SHC Patient

Excellent doctor.

Jul 2021

•

Verified SHC Patient

Very good, the patient always look forward for the time of his appointment, he also share it with his family and friends.

Sep 2016

•

Verified SHC Patient

In this Dermatology Department & Laboratory they are very kind & attentive with the patient they make you feel confident & if there is a wait or delay they let you know so there is no restlessness.

Aug 2016

•

Verified SHC Patient

Dr. Marinkovich took time explaining to me my mother's conditions, potential treatment options, and testing that need to be done define her issues. He even gave me his mobile phone number and email in case I need to contact him. I am 62 years old and have seen many doctors and this is the first time I experienced this personal gesture. Dr. Leon Hsu also demonstrated his concerns for my mother.

May 2016

•

Verified SHC Patient

Dr. Marinkovich is fantastic. Dr. Chiou was excellent as well. I'm reassured that I am in such good hands.

Apr 2016

•

Verified SHC Patient

Very professional, very understanding doctor!

Jan 2016

•

Verified SHC Patient

I felt a bit rushed, but fortunately I was able to take away what I needed to know.

Nov 2015

•

Verified SHC Patient

DR. Marinkovich and staff are awesome...very helpful and sincere in his concern for my health.

Oct 2015

•

Verified SHC Patient

great doctor!

Aug 2015

•

Verified SHC Patient

Dr. Marinkovich's care and treatment are exemplary.

Nov 2014

•

Verified SHC Patient

I always feel blessing that I am receiving care from this provider.

Nov 2014

•

Verified SHC Patient

Dr. Marinkovich responded to an email I sent on a holiday weekend - and followed up with two additional ones. AWESOME!

Jun 2014

•

Verified SHC Patient

Dr. Marinkovich is very caring and sympathetic. I also have complete confidence in his abilities and would highly recommend him to others with a similar illness.

Mar 2014

•

Verified SHC Patient

Good.

Feb 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

M. Peter Marinkovich, MD

Dermatologist, Blistering disease specialist, Psoriasis specialist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Blistering Disease Clinic Redwood City, CA

Blistering Disease Clinic

Skin Cancer Program in Palo Alto Palo Alto, CA

Skin Cancer Program in Palo Alto

General Dermatology Clinic in Redwood City Redwood City, CA

General Dermatology Clinic in Redwood City

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Review Summary

Patient Reviews

(28 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

M. Peter Marinkovich, MD

Dermatologist, Blistering disease specialist, Psoriasis specialist

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Specializing In

Practice Locations

Blistering Disease Clinic Redwood City, CA

Blistering Disease Clinic

Skin Cancer Program in Palo Alto Palo Alto, CA

Skin Cancer Program in Palo Alto

General Dermatology Clinic in Redwood City Redwood City, CA

General Dermatology Clinic in Redwood City

Important Information about Our Organizations and Physician Affiliation

Patient Ratings

How Our Ratings Work

Review Summary

Patient Reviews

(28 reviews)

Referring Physicians

PHYSICIAN HELPLINE